CIRCULATING TUMOR DNA ANALYSIS OF ADVANCED HEPATOCELLULAR CANCER (HCC) PATIENTS TREATED WITH NEOANTIGEN TARGETED PERSONALIZED CANCER DNA VACCINE (GNOS-PV02) IN COMBINATION WITH PLASMID IL-12 (PIL12) AND ANTI-PD1 (PEMBROLIZUMAB)

Category Primary study
JournalJournal for ImmunoTherapy of Cancer
Year 2022
This article has no abstract
Epistemonikos ID: 791ebdf4135f4da13de05a2181072253f46e77d4
First added on: Feb 15, 2025